Author

Francesco Topi

University of HelsinkiORCID 0009-0006-6498-8195Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Axel T. BrüngeriD· 1 shared Chuchu WangiD· 1 shared Giuseppe BalistreriiD· 1 shared John KuriyaniD· 1 shared Jussi HepojokiiD· 1 shared K. Ian WhiteiD· 1 shared Kailu YangiD· 1 shared Lauri KareineniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Axel T. BrüngerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintNov 2, 2026

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Kailu Yang, Chuchu Wang, Francesco Topi…·Axel T. Brünger

This study designs and validates protease-resistant antiviral peptides that inhibit SARS-CoV-2 fusion, showing improved efficacy in vitro and in vivo.

DOI 10.64898/2026.09.12.750390

humanproteomics

𝕏 PostBluesky